Singlomics Announces First Patient Dosed in Phase I Clinical Trial of DXP-106 (IL-1RAP mAb) in China
Singlomics Biopharmaceuticals, an innovative clinical-stage biopharmaceutical company focused on the discovery and development of antibody therapeutics for oncology, inflammation, and autoimmune ...
The biotechnology company administered its IL-1RAP antibody to the initial participant in early-stage testing for ...
Learn what the Nipah virus is, how it spreads, and why it has one of the highest fatality rates among infectious diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results